BridgeMD
Compares treatment options for Post Operative Pain in Total Abdominal Hystrectomy
Official title Comparison Between Tranversus Abdominis Plane (TAP) Block With Only Bupivacaine and TAP Block With Bupivacaine Plus Ketamine in Reducing Postoperative Pain After Total Abdominal Hystrectomy
ClinicalTrials.gov ID: NCT07482709
What this study is testing
What is bupivicaine 0.25%?
bupivicaine 0.25% is an investigational medicine, being studied as a potential treatment for post operative pain in total abdominal hystrectomy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this study is to know how effectively TAP block can reduce postoperative pain in total abdominal hystrectomy patients when given ketamine in addition to bupivacaine in TAP block and to compare it with the conventional TAP block with bupivacaine only. The main question it aims to answer is: Does intervention with ketamine in TAP block lowers the postoperative pain measured via visual analog scale and decreases the need for rescue analgesia?
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 65, women only
You may be able to join if
- Aged between 25 to 60 years.
- ASA grade I \& II.
- Undergoing total abdominal hysterectomy.
You likely can't join if
- BMI \>35kg/m2.
- Patient refusal for participation.
- Patients with coagulation disorders.
- Patents with history of allergy and hypersensitivity to local anesthetic.
- Patient having infection at the injection site.
- Alcohol or drug abuse.
See the full eligibility criteria
- Aged between 25 to 60 years.
- ASA grade I \& II.
- Undergoing total abdominal hysterectomy.
- BMI \>35kg/m2.
- Patient refusal for participation.
- Patients with coagulation disorders.
- Patents with history of allergy and hypersensitivity to local anesthetic.
- Patient having infection at the injection site.
- Alcohol or drug abuse.
- Cognitive or mental disorder.
The study team makes the final eligibility decision.
Where it's taking place
- Karachi, Sindh, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Karachi, Sindh, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.